B-cell depleting monoclonal antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for B-cell depleting monoclonal antibody, covering 2025-12-10 to 2025-12-10. Get the full timeline:
Most recent: Clinical Trial Update: AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus [Phase 1]